Studies have shown that mutations activating the PI3K/AKT signaling pathway, along with the inactivation of the TP53 tumor suppressor gene, are common mechanisms for cancer cell proliferation and evasion of programmed cell death. The gene discussed is TP53; the disease is cancer.